SEC Filing Summary: Ekso Bionics Holdings, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on February 26, 2021, by Ekso Bionics Holdings, Inc., a Nevada corporation. The report details corporate governance events regarding the scheduling of the 2021 Annual Meeting of Stockholders. Note: The input metadata references "Chronoscale Holdings Corp," but the filing text explicitly identifies the registrant as Ekso Bionics Holdings, Inc.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder meeting logistics and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the Board of Directors' determination on February 24, 2021, to schedule the 2021 Annual Meeting of Stockholders for Thursday, June 10, 2021.
Guidance, Outlook, and Corporate Governance
Management has established specific deadlines for stockholder proposals and director nominations under the Company's By-laws:
- Proposal/Nomination Deadline: Written notice must be received by the Corporate Secretary no later than March 12, 2021.
- Exclusion Deadline: Notice of proposals not submitted for inclusion in the proxy statement must be received no later than April 14, 2021.
- Compliance: All proposals must comply with Nevada law, SEC regulations, and the Company's By-laws. Untimely notices will not be entertained.
Key Facts for Investor Verification
- Verify the exact time and location of the Annual Meeting in the upcoming proxy statement, as these details were not included in this 8-K.
- Confirm the March 12, 2021, and April 14, 2021, deadlines for submitting stockholder proposals or director nominations.
- Note that the registrant is Ekso Bionics Holdings, Inc., trading under the symbol EKSO on the Nasdaq Capital Market.